Next Article in Journal
“First Do No Harm”. No-Fault Compensation Program for COVID-19 Vaccines as Feasibility and Wisdom of a Policy Instrument to Mitigate Vaccine Hesitancy
Next Article in Special Issue
Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
Previous Article in Journal
Use of Stability Modeling to Support Accelerated Vaccine Development and Supply
 
 
Article

Article Versions Notes

Vaccines 2021, 9(10), 1115; https://doi.org/10.3390/vaccines9101115
Action Date Notes Link
article xml file uploaded 30 September 2021 14:55 CEST Original file -
article xml uploaded. 30 September 2021 14:55 CEST Update https://www.mdpi.com/2076-393X/9/10/1115/xml
article pdf uploaded. 30 September 2021 14:55 CEST Version of Record https://www.mdpi.com/2076-393X/9/10/1115/pdf
article supplementary file uploaded. 30 September 2021 14:55 CEST - https://www.mdpi.com/2076-393X/9/10/1115#supplementary
article html file updated 30 September 2021 14:56 CEST Original file -
article html file updated 30 July 2022 08:43 CEST Update https://www.mdpi.com/2076-393X/9/10/1115/html
Back to TopTop